Ascend Wellness

Overview
News
Cannabis?
Product stageSegments
Expansion
?
Cultivators, Dispensaries, Extractors and infusers
?

Ascend Wellness Holdings, Inc. is a multi-state, vertically integrated cannabis operator specializing in the cultivation, production, and retail of cannabis products. The company owns and operates state-of-the-art cultivation facilities where they grow award-winning strains. Ascend Wellness produces and distributes its in-house brands, including Common Goods, Simply Herb, Ozone, Ozone Reserve, Tunnel Vision, and Royale. Their product offerings encompass a diverse range of cannabis products, such as premium flower, pre-rolls, edibles, vaporizers, concentrates, topicals, and accessories.

As of June 2024, Ascend Wellness operates 37 dispensaries across seven states: Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania. The company recently opened a new dispensary in Wharton, New Jersey, featuring a drive-thru option, further enhancing customer convenience. Additionally, they celebrated the opening of their fourth medical dispensary in Cranberry, Pennsylvania, in June 2024, and their tenth dispensary in Illinois in November 2023.

Ascend Wellness prioritizes affordability and accessibility, offering everyday low prices and an outlet model in select locations. Their dispensaries provide a welcoming environment, knowledgeable staff, and efficient service, ensuring minimal wait times for customers. The company also offers a loyalty program, Ascenders Club, where customers earn points for every dollar spent and receive bonus points for referrals.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
137 Lewis Wharf Boston MA USA
Founded year:
2018
Employees:
1,001-5,000
IPO status:
Public
Total funding:
USD 751.2 mn
Last Funding:
USD 235.0 mn (Post IPO Debt; Jul 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.